FDA Inspection
Belleview 402 LLCBelleview 402 LLC – FDA Inspection, Mar 30, 2012
Record Details
This FDA Inspection record concerns Belleview 402 LLC, with an inspection on March 30, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Belleview 402 LLC
- Inspection Date
- March 30, 2012
- Product Type
- Drugs
View Company Profile
ID · e76660bc-a11f-40a5-a553-0204c1945b6c
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 774592
- FDA center
- Human Drugs
- Project area
- Unapproved and Misbranded Drugs
FDA Citations
3- 21 CFR 211.166(b)Adequate number of batches on stability
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.180(e)(2)Items to cover on annual reviews
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Belleview 402 LLC
16| Date | Classification | Office | Project area |
|---|---|---|---|
| March 15, 2024 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 20, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 15, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 25, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 1, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Belleview 402 LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.